Alexander's, Inc (ALX) Stock Price

234.54 ▲ +2.73 (+1.18%)
Open: 233.63 Vol: 75.6K Day's range: 231.99 - 236.99 Oct 24, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 234.07▲ 234.07▲ 234.07▲ 233.74▲ 235.61▼
MA10 233.88▲ 233.23▲ 232.37▲ 233.91▲ 234.92▼
MA20 233.55▲ 232.07▲ 232.25▲ 235.72▼ 233.96▲
MA50 232.12▲ 233.40▲ 234.02▲ 233.77▲ 218.71▲
MA100 233.02▲ 233.96▲ 235.61▼ 233.67▲ 219.80▲
MA200 234.27▲ 236.11▼ 236.32▼ 220.01▲ 218.99▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.008▲ 0.479▲ 0.485▲ -0.397▼ -0.734▼
RSI 57.857▲ 60.108▲ 56.651▲ 49.440▼ 52.633▲
STOCH 59.859     61.709     67.019     42.107     54.921    
WILL %R -14.688▲ -19.496▲ -19.300▲ -58.264     -52.758    
CCI 143.138▲ 99.112     101.461▲ -16.092     -16.837    
Latest Filters Detected On ALX
MA $ALX Price Crossed Above MA(50) Set Alert
MA $ALX Price Crossed Above MA(13) Set Alert
MA $ALX Price Crossed Above MA(7) Set Alert
Alexander's, Inc News
Alx Oncology stock jumps after presenting preclinical ADC data at conference
Thursday, October 23, 2025 10:30 AM
Investing.com -- Alx Oncology Holdings Inc. (NASDAQ:ALXO) stock surged 10.6% on Thursday after the clinical-stage biotechnology company presented preclinical data for its antibody-drug conjugate (ADC) ...
ALX presents preclinical data, Phase 1 trial-in-progress for ALX2004
Thursday, October 23, 2025 09:45 AM
ALX Oncology (ALXO) presented preclinical data and the trial design for the ongoing Phase 1 clinical trial for its ADC candidate, ALX2004, in two ...
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
Thursday, October 23, 2025 09:43 AM
Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical ...
ALX historical stock data
date open high low close volume
24/10/25 233.63 236.99 231.99 234.54 75,600
23/10/25 233.22 236.70 228.45 231.81 75,400
22/10/25 233.22 235.00 230.50 233.66 70,858
21/10/25 238.25 238.63 231.47 232.19 65,100
20/10/25 238.09 238.52 233.25 236.50 66,300
17/10/25 231.48 236.03 229.00 235.87 79,900
16/10/25 236.46 240.84 231.37 232.30 88,100
15/10/25 233.47 239.00 232.58 236.91 94,200
14/10/25 232.39 233.76 228.05 232.97 67,900
13/10/25 231.95 236.15 230.36 232.34 91,200
Quote Details
52wk Low:184.76
52wk High:260.84
Vol:75.6K
Avg Vol(3m):1.3M
1Y Chng:+1.89%
1M Chng:-3.33%
Add to Watch List
More Information
Index N/A
Market Cap. 1.20B